Diabetes as a coronary artery disease risk equivalent: before a change of paradigm? (Q39925805)

15 September 2017

Diabetes as a coronary artery disease risk equivalent: before a change of paradigm? (English)

1 reference

15 September 2017

coronary artery disease

1 reference

Christoph H Saely

1

1 reference

15 September 2017

Stefan Aczel

2

1 reference

15 September 2017

Lorena Koch

3

1 reference

15 September 2017

Fabian Schmid

4

1 reference

15 September 2017

Thomas Marte

5

1 reference

15 September 2017

Kurt Huber

6

1 reference

15 September 2017

Heinz Drexel

7

1 reference

15 September 2017

1 February 2010

1 reference

European Journal of Cardiovascular Prevention and Rehabilitation

15 September 2017

1 reference

15 September 2017

17

1 reference

15 September 2017

1

1 reference

15 September 2017

94-99

1 reference

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

15 September 2017

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Sex differences in the effect of diabetes duration on coronary heart disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Diabetes and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Diabetes and all-cause and coronary heart disease mortality among US male physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Is diabetes a coronary risk equivalent? Systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Lipid-lowering treatment for all could substantially reduce the burden of macrovascular complications of diabetes patients in the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

The Gender-Specific Impact of Diabetes and Myocardial Infarction at Baseline and During Follow-Up on Mortality From All Causes and Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E32833100F0

10.1097/HJR.0B013E32833100F0

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference